Holen Sie sich die Stockscreener-App
188.50
0.20%
-0.48
Ishares Biotechnology Etf Aktie (IBB) Neueste Nachrichten
iShares Global Healthcare ETF vs VanEck Biotech ETF: Which ETF Is Better for Profiting With Healthcare in 2026? - The Motley Fool
Which iShares Healthcare ETF Is the Better Buy: Diversified IXJ or Biotech-Focused IBB? - The Motley Fool
iShares Biotechnology ETF (rIBB) Price Prediction - Bitget
Is the iShares Healthcare ETF or the Invesco Nasdaq Biotech ETF the Better Bet for Investors in 2026? - The Motley Fool
Which Healthcare ETF Is the Better Buy: iShares' Global IXJ or First Trust's Biotech FBT? - The Motley Fool
IXJ vs. IBBQ: Global Healthcare vs. Biotech -- Which ETF Is the Better Buy? - The Globe and Mail
Understanding the Shape of the iShares Biotechnology ETF Portfolio - sekbernews.id
IBB ETF Holds Fewer Bets Than You Think - Trefis
$188.977 | iShares Biotechnology ETF (IBB) Stock Price Today - Binance
Biotech ETFs: How Do FBT and IBB Match Up on Cost, Structure, and Performance? - AOL.com
Should You Invest in the VanEck Biotech ETF (BBH)? - Yahoo Finance
Biotech ETFs: How Do FBT and IBB Match Up on Cost, Structure, and Performance? - The Motley Fool
Healthcare ETFs Face-Off: Stability vs. Biotech Growth, Which Strategy Wins? - finance.biggo.com
5 Best Biotech ETFs for 2026 and How to Invest - The Motley Fool
IHE vs. IBB: Which iShares Healthcare ETF Is the Better Buy? - The Motley Fool
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now? - Yahoo Finance
iShares NASDAQ Biotechnology ETF declares quarterly distribution of $0.0238 - MSN
Cramer’s mad dash: iShares Biotechnology ETF - MSN
iShares Biotechnology ETF(IBB) Stock Options Chain | Quotes & News - Moomoo
Cramer’s Mad Dash: iShares Biotechnology ETF - CNBC
Vanguard Health Care vs. iShares Biotech: How Do These ETFs Stack Up? - The Motley Fool
IBBiShares Biotechnology ETF Dividends - Finviz
RXRX rallies past biotech ETFs as short interest, insider-sale filings shape coming week - TechStock²
SPDR Health Care ETF Tops iShares Biotech in Long-Term Returns - The Motley Fool
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? - Yahoo Finance
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? - Yahoo Finance
Healthcare Stocks Got A Late Lift From Big Headlines - Finimize
Greece’s Return and a Chip Meltdown: MSCI World ETF Caught Between Index History and Market Chaos - Ad-hoc-news.de
How Ishares Biotechnology Etf (IBB) Affects Rotational Strategy Timing - Stock Traders Daily
The biotech sector looks ready for a multi-year breakout: Here's what to watch - MSN
The Biotech Sector Looks Ready for a Multi-Year Breakout—Here's What to Watch. - MarketBeat
Biotech ETFs Gain Momentum via AI Drug Discovery & Surging M&A - ETF Database
Biotech's Silent Resurgence (5-Year Base Breakout) - TradingView
Biotech breakout: iShares Biotechnology ETF hits all-time high - Seeking Alpha
Why Is Natera Stock Gaining Tuesday? - Benzinga
Biotech ETFs Put Up Strong Show in 1H 2026: More Gains Ahead? - TradingView
Biotech ETF hits record as AbbVie seals $10.9B Apogee deal - MSN
Sector Update: Healthcare - Moomoo
As AbbVie eyes Apogee, these biotech stocks earn the highest Quant ratings (IBB:NASDAQ) - Seeking Alpha
DFTX Stock Rallies Ahead Of High-Stakes Phase 3 Depression Drug Trial Results — What Investors Need To Know - TradingView
Should You Invest in the iShares Biotechnology ETF (IBB)? - Yahoo Finance
Syntax Bio expands Series A to $14.4M, adds leadership and board members (IBB:NASDAQ) - Seeking Alpha
2Seventy Bio Inc (TSVT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CARGO Therapeutics Inc (CRGX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Biomea Fusion Inc (BMEA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CureVac NV (CVAC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
0.45%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):